Earlier this month, House Representative Earl L. (“Buddy”) Carter (R-GA) introduced the Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613) (the “Act”) in an effort to improve transparency and curb abusive practices related to the... Read More
Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Articles | Medicare Advantage Risk Adjustment Litigation | Medicare Audit Appeals | Plan Sponsor PBM Contract Services

Frier Levitt has been closely monitoring Express Scripts’ (“ESI”) administration of TRICARE, the health care program for uniformed service members and their families. Earlier this year the Defense Health Agency (“DHA”) awarded ESI a... Read More
Chain Pharmacies | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Uncategorized

On June 15, 2022, the Supreme Court of the United States ruled unanimously in favor of several hospital groups concluding that the Department of Health and Human Services (HHS) exceeded its statutory authority by implementing a discriminatory... Read More
340B Covered Entity and Contract Pharmacy Regulatory and Contract Support | Articles | Healthcare Litigation | Hospitals and Healthcare Systems | Medicare and Insurance Audits